Subtopic Deep Dive
HIV Insulin Resistance Mechanisms
Research Guide
What is HIV Insulin Resistance Mechanisms?
HIV insulin resistance mechanisms describe pathways linking chronic inflammation, visceral adiposity, and antiretroviral therapy (ART) to impaired glucose homeostasis in HIV-infected individuals.
Mechanistic studies identify adipokine dysregulation as central to insulin resistance in HIV patients on ART. Observational cohorts report elevated dysglycemia risks foreshadowing diabetes epidemics among survivors. Over 10 key papers since 2001 document metabolic shifts, with Friis-Møller et al. (2003) cited 1665 times linking ART to cardiovascular risks including dysglycemia.
Why It Matters
Dysglycemia in HIV patients increases diabetes incidence, complicating long-term ART adherence and survival. Triant et al. (2007, 1602 citations) showed doubled acute myocardial infarction rates tied to metabolic factors like insulin resistance. Hadigan et al. (2001, 678 citations) quantified lipodystrophy-associated glucose impairments versus Framingham controls, informing metformin RCTs and lifestyle guidelines (Aberg et al., 2009). These mechanisms drive targeted interventions averting cardiometabolic epidemics in aging HIV cohorts (Smit et al., 2015).
Key Research Challenges
Disentangling ART Effects
Distinguishing direct ART toxicity from HIV-driven inflammation challenges causality attribution. Friis-Møller et al. (2003) observed myocardial risks in 23,468 patients but could not isolate insulin pathways. Longitudinal designs struggle with confounding by viral load and adherence.
Quantifying Adipokine Dysregulation
Measuring adiponectin-leptin imbalances requires matched controls accounting for lipodystrophy. Hadigan et al. (2001) compared 71 HIV patients to 213 Framingham subjects, revealing metabolic gaps. Assay variability limits cross-study synthesis.
RCT Design for Interventions
Testing metformin or lifestyle fixes demands powering for rare diabetes endpoints in heterogeneous cohorts. Guidelines (Gazzard, 2008; Aberg et al., 2009) recommend surrogates like HOMA-IR, but hard outcomes lag. Aging populations add comorbidity noise (Smit et al., 2015).
Essential Papers
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
Nina Friis‐Møller, Caroline Sabin · 2003 · New England Journal of Medicine · 1.7K citations
BACKGROUND It remains controversial whether exposure to combination antiretroviral treatment increases the risk of myocardial infarction. METHODS In this prospective observational study, we enrolle...
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
Virginia A. Triant, Hang Lee, Colleen Hadigan et al. · 2007 · The Journal of Clinical Endocrinology & Metabolism · 1.6K citations
Abstract Context: Metabolic changes and smoking are common among HIV patients and may confer increased cardiovascular risk. Objective: The aim of the study was to determine acute myocardial infarct...
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano, Ian Graham, Guy De Backer et al. · 2016 · Atherosclerosis · 1.6K citations
British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008
B G Gazzard, on behalf of the BHIVA Treatment Guidelines Writing Group · 2008 · HIV Medicine · 1.1K citations
Table of contents 1.0 Introduction 2.0 Methodology 2.1 Basing recommendations on evidence 2.2 Implications for research 2.3 Use of surrogate marker data 2.4 Issues concerning design and analysis of...
Future challenges for clinical care of an ageing population infected with HIV: a modelling study
Mikaëla Smit, Kees Brinkman, Suzanne E. Geerlings et al. · 2015 · The Lancet Infectious Diseases · 899 citations
Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV
Anoop Shah, Dominik Stelzle, Kuan Ken Lee et al. · 2018 · Circulation · 879 citations
Background: With advances in antiretroviral therapy, most deaths in people with HIV are now attributable to noncommunicable illnesses, especially cardiovascular disease. We determine the associatio...
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Judith A. Aberg, Jonathan E. Kaplan, Howard Libman et al. · 2009 · Clinical Infectious Diseases · 839 citations
Abstract Evidence-based guidelines for the management of persons infected with human immunodeficiency virus (HIV) were prepared by an expert panel of the HIV Medicine Association of the Infectious ...
Reading Guide
Foundational Papers
Start with Friis-Møller et al. (2003, 1665 citations) for ART risk discovery in 23,468 patients; Triant et al. (2007, 1602 citations) for AMI rates and metabolic links; Hadigan et al. (2001, 678 citations) for lipodystrophy insulin data versus controls.
Recent Advances
Smit et al. (2015, 899 citations) models aging HIV cardiometabolic burdens; Shah et al. (2018, 879 citations) quantifies global CVD in HIV; Catapano et al. (2016, 1577 citations) updates dyslipidemia management relevant to insulin resistance.
Core Methods
Prospective cohorts (e.g., D:A:D in Friis-Møller); case-control matching (Hadigan); surrogate markers like HOMA-IR (Aberg 2009); modeling for projections (Smit 2015).
How PapersFlow Helps You Research HIV Insulin Resistance Mechanisms
Discover & Search
Research Agent uses searchPapers('HIV insulin resistance ART mechanisms') to retrieve 50+ papers including Triant et al. (2007), then citationGraph maps Friis-Møller et al. (2003) clusters linking ART to dysglycemia, while findSimilarPapers expands to lipodystrophy studies like Hadigan et al. (2001). exaSearch drills into adipokine assays across 250M+ OpenAlex papers.
Analyze & Verify
Analysis Agent applies readPaperContent on Hadigan et al. (2001) to extract HOMA-IR data from 71 patients versus Framingham controls, then runPythonAnalysis computes effect sizes with pandas (e.g., glucose AUC differences). verifyResponse via CoVe cross-checks claims against Triant et al. (2007); GRADE grading scores cohort evidence as moderate for ART risks.
Synthesize & Write
Synthesis Agent detects gaps like missing RCT data on metformin in ART users, flags contradictions between Friis-Møller (2003) and Bozzette (2003) on event rates. Writing Agent uses latexEditText for mechanism diagrams, latexSyncCitations integrates 10 papers, latexCompile outputs review sections; exportMermaid visualizes inflammation-adiposity pathways.
Use Cases
"Extract glucose homeostasis data from HIV lipodystrophy papers and plot insulin resistance trends"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Hadigan 2001) → runPythonAnalysis (pandas plot HOMA-IR vs controls) → matplotlib figure of metabolic shifts.
"Draft LaTeX review on ART-linked insulin resistance mechanisms with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText (mechanisms section) → latexSyncCitations (Friis-Møller 2003, Triant 2007) → latexCompile → PDF with adipokine pathway diagram.
"Find code for modeling HIV dysglycemia risks from papers"
Research Agent → searchPapers('HIV insulin resistance') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for cohort simulation from Smit 2015 modeling.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers → citationGraph on Triis-Møller (2003) → structured report grading ART-dysglycemia evidence (GRADE moderate). DeepScan's 7-steps verify Triant (2007) AMI rates against Hadigan (2001) via CoVe checkpoints and runPythonAnalysis on risk factors. Theorizer generates hypotheses linking adipokines to future RCTs from guideline gaps (Aberg 2009).
Frequently Asked Questions
What defines HIV insulin resistance mechanisms?
Pathways connect chronic inflammation, ART-induced visceral adiposity, and adipokine shifts to glucose impairment. Friis-Møller et al. (2003) first quantified ART myocardial risks in 23,468 patients.
What methods study these mechanisms?
Cohorts compare HIV patients to Framingham controls (Hadigan et al., 2001); guidelines recommend HOMA-IR surrogates (Gazzard 2008, Aberg 2009). RCTs test metformin amid lipodystrophy.
What are key papers?
Friis-Møller et al. (2003, 1665 citations) on ART infarction risk; Triant et al. (2007, 1602 citations) on AMI doubling; Hadigan et al. (2001, 678 citations) on lipodystrophy metabolism.
What open problems remain?
Causality between specific ART drugs and adipokine dysregulation; long-term RCT outcomes in aging cohorts (Smit et al., 2015); personalized interventions beyond metformin.
Research HIV-related health complications and treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching HIV Insulin Resistance Mechanisms with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers